Download PDF

Other users also viewed these articles

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy Joan Martínez-Campreciós; Mar Riveiro-Barciela; Raquel Muñoz-Gómez; María-Carlota Londoño; Mercé Roget; Miguel Ángel Serra; Desamparados Escudero-García; Laura Purchades; Manuel Rodríguez; Juan E. Losa-García; María L. Gutiérrez; Isabel Carmona; Javier García-Samaniego; Luís Morano; Ignacio Martín-Granizo; Marta Montero-Alonso; Martín Prieto; Manuel Delgado; Natalia Ramos; María A. Azancot; Francisco Rodríguez-Frías; Maria Buti;
Gastroenterol Hepatol. 2023;46:594-602
Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C Georgios Neokosmidis; Adonis A. Protopapas; Dimitrios Stogiannou; Athanasios Filippidis; Konstantinos Tziomalos;
Gastroenterol Hepatol. 2023;46:58-66
Hepatitis B and C screening in hospitalized patients with SARS-CoV-2 infection Judith Gómez Camarero; Ester Badia Aranda; Raisa Quiñones Castro; Rosa María Saiz Chumillas; Laura Alcoba Vega; Sandra Díez Ruiz; Noemí Gómez Manero; Raquel Vinuesa Campo; Francisco Jorquera Plaza;
Gastroenterol Hepatol. 2022;45:256-64